Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium hyaluronate concentration comparison after endothelial keratoplasty
ChiCTR-IPR-17013063Phase 4Recruiting
- Sponsor
- Peking University Third Hospital
- Start
- Oct 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of sodium hyaluronate in keratopathy and ocular surface injuries (2 arms), sponsored by Peking University Third Hospital. Primary endpoint: corneal fluorescein staining. Started Oct 2017; status: recruiting.
02
Drugs
sodium hyaluronate
03
Conditions
keratopathyocular surface injuries
Beyond the preview
Go deeper on ChiCTR-IPR-17013063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17013063.